Heerspink is a consultant for AstraZeneca, Alexion, Bayer, Boehringer Ingelheim, CSL-Behring, DIMERIX, Eli Lilly, Gilead, Janssen, Novartis, Novo Nordisk , Roche, Travere Pharmaceuticals and VIFOR Pharma
doi: 10.1016/bs.mie.2021.12.012
Cagrilintide: Unique CNS appetite suppression, enhanced gastric emptying delay, paired satiety signaling Mix: Combined appetite suppression through dual pathways The Amylin Mechanism: Understanding Cagrilintides Innovation The cagrilintide peptide starts the amylin receptor pathway for appetite regulation: Amylin Receptor Activation: Central nervous system appetite suppression
Unlike once-weekly injections, sublingual drops are typically taken daily
A major review in Nature Metabolism concluded that preclinical studies are promising, but that human clinical trials have so far shown a more limited and context-dependent effect